Using AI for drug discovery
Location: United States, California, San Francisco
Total raised: $24M
Investors 1
| Date | Name | Website |
| - | AIX Ventur... | aixventure... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.12.2022 | Seed | $12M | - |
| 12.08.2022 | - | $12M | - |
Mentions in press and media 5
| Date | Title | Description |
| 13.06.2024 | AWS Announces $230 Million Commitment for Generative AI Startups | Funds will help the next generation of startups turbocharge development of new generative AI applications and bring innovations to market faster AWS Generative AI Accelerator program will add another 80 early-stage startups from around the ... |
| 09.12.2022 | Vevo Therapeutics Launches With $12M Seed | SAN FRANCISCO, CA, Vevo Therapeutics has launched with an oversubscribed and upsized $12 million seed financing round. >> Click here for more funding data on Vevo Therapeutics >> To export Vevo Therapeutics funding data to P... |
| 08.12.2022 | Vevo Therapeutics Raises $12M in Seed Financing | Vevo Therapeutics, a San Francisco, CA-based biotechnology company, raised $12M in Seed funding. The round was led by Wing Venture Capital and General Catalyst with participation from Mubadala Capital, AIX Ventures, and Camford Capital. The... |
| 12.08.2022 | Vevo Launches with $12M to Scale Vivo Data Generation to Discover Better Drugs | What You Should Know: – Vevo will combine its atlas with AI models to capture in vivo context of disease and better represent patient diversity in drug response over current in vitro assays. For example, in a single in vivo experiment, the ... |
| - | Vevo Therapeutics | “The world’s first in vivo guided drug discovery platform, combining in vivo data and artificial intelligence to discover drugs that work in humans.” |